Robin Humphreys

Robin Humphreys is an accomplished Executive Director at Jazz Pharmaceuticals, with a career spanning over two decades in the biopharmaceutical industry. Previously serving as a Senior Director at Jazz Pharmaceuticals, Robin has held key leadership positions at companies such as Northern Biologics and Ambrx, where expertise in drug development and preclinical sciences was demonstrated. A strong background in oncology research was established at Human Genome Sciences and HGS, where Robin led successful cancer therapeutic programs into early clinical trials. Educational qualifications include a Ph.D. in Cell Biology from Baylor College of Medicine and a BSc. in Biochemistry from the University of Arizona. Notably, significant contributions to cancer research were marked during a tenure at the National Institutes of Health, including the development of innovative mouse models of breast cancer.